SCHEMBL6424563

SCHEMBL6424563

CCOC(=O)C(C)N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
USP2 O75604 1/20 0.45
HTT P42858 3/20 0.44
ATM Q13315 1/20 0.44
ALDH1A1 P00352 3/20 0.42
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
POLB P06746 1/20 0.41
CASP6 P55212 1/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR1H2 P55055 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
RECQL P46063 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31394412 0.86 SMN1; SMN2 (0.46) SMN1; SMN2USP2HTTATMALDH1A1
SCHEMBL1514910 0.84 USP2 (0.47) SMN1; SMN2USP2HTTATMALDH1A1
SCHEMBL20399124 0.84 USP2 (0.47) SMN1; SMN2USP2HTTATMALDH1A1
SCHEMBL6421570 0.84 SMN1; SMN2 (0.44) SMN1; SMN2USP2HTTALDH1A1GAA
SCHEMBL1189317 0.84 ALDH1A1 (0.56) SMN1; SMN2USP2HTTALDH1A1GAA
SCHEMBL25037210 0.82 SMN1; SMN2 (0.43) SMN1; SMN2USP2HTTATMALDH1A1
SCHEMBL6129180 0.82 ALDH1A1 (0.46) SMN1; SMN2HTTALDH1A1GAAPKM
SCHEMBL12788644 0.81 KMT2A (0.44) SMN1; SMN2HTTALDH1A1GAAPKM
SCHEMBL2538012 0.81 SMN1; SMN2 (0.42) SMN1; SMN2USP2HTTATMALDH1A1
SCHEMBL25037204 0.81 SMN1; SMN2 (0.42) SMN1; SMN2USP2HTTATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077942-B1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMA INC (US) 2005-01-12 EP disclosed
US-6316445-B1 TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. 2001-11-13 US disclosed
EP-0946545-B1 NOVEL CARBOXY SUBSTITUTED CYCLIC CARBOXAMIDE DERIVATIVES AVENTIS PHARMA INC (US) 2001-09-05 EP disclosed
EP-1077942-A1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS Aventis Pharmaceuticals Inc. (US) 2001-02-28 EP disclosed
WO-1999059972-A1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 1999-11-25 WO disclosed
US-5977139-A Carboxysubstituted cyclic carboxamide derivatives HOECHST MARION ROUSSEL, INC. (US) 1999-11-02 US disclosed
EP-0946545-A1 NOVEL CARBOXY SUBSTITUTED CYCLIC CARBOXAMIDE DERIVATIVES HOECHST MARION ROUSSEL, INC. (US) 1999-10-06 EP disclosed
WO-1998027085-A1 NOVEL CARBOXY SUBSTITUTED CYCLIC CARBOXAMIDE DERIVATIVES HOECHST MARION ROUSSEL, INC. (US) 1998-06-25 WO disclosed